LanceBio Ventures
Biotech Investment Powerhouse
› Over $200m deployed in early stage biotech companies through investments and strategic deals
› 360˚ knowledge of the sector. Evolution stages: Academia, In-house Industrial R&D, Corporate VC and Business Development, Professional Regulated Public Equities Asset Management
› 13 private early stage biotech companies invested. More than 30 public early stage biotech companies invested (8 IPOs, 4 strategic deals, 7 M&A, realized net cash IRR for investors up to 59%)
› Deep scientific and biotech VC expertise
› Top positions in venture and production biotech companies in USA, Russia, Canada, EU: Pharmstandard, Generium, Aquinox, Protagonist, Codon, Allena, Transmedics and others